Bioengineers at the National Institute of Biomedical Imaging and Bioengineering (NIBIB) are asking big questions—and striking up trans-NIH collaborations to answer them. And by joining forces with researchers across NIH’s intramural research program (IRP), they’re moving discovery into entirely new places. Read more at the NIH Catalyst.

NIBIB-funded researchers are developing a robotic pill that, after swallowing, can deliver biologic drugs into the stomach, which could provide an alternative method for self-injection for a wide range of therapies.

RADx Tech program has issued contracts to help meet the ongoing needs and challenges of COVID-19 diagnostic testing.

The National Institutes of Health’s Rapid Acceleration of Diagnostics (RADx®) Tech program is working to identify necessary elements of at-home COVID-19 diagnostic test kits that may be used independently by people with disabilities.

This Associated Press interview with NIBIB Director Dr. Bruce Tromberg delves into COVID-19 infectiousness and COVID-19 antigen tests.

This article describes self-test reporting mechanisms used in the CDC-NIH Say Yes! COVID Test program. The pilot demonstrates that it is possible to establish an efficient and scalable electronic pathway for self-test result reporting to public health authorities.

The NIH recently invested over $74 million over five years to support 19 DS-I Africa awards that will conduct research and training activities across the continent.

How much should you trust the results of a rapid antigen test? That's a question many people are asking these days amid recent research and anecdotes suggesting these tests may be less sensitive to omicron. Researchers are working fast to figure out what's going on and how to improve the tests. Source: NPR.

NIBIB-funded researchers have found a way to model the human neuromuscular junction by growing these synapses in a lab, which could accelerate novel treatments for neuromuscular diseases.